Cost-Effectiveness of MiniMed 780G Therapy Compared with Multiple Daily Injections (MDI) with Intermittently Scanned Continuous Glucose Monitoring (isCGM) in People with Type 1 Diabetes (T1D)-A United States Perspective

被引:0
|
作者
Kommareddi, Mallika
Wherry, Kael
机构
关键词
D O I
10.2337/db23-999-P
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
999-P
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Long-Term Cost-Effectiveness the Dexcom G6 Real-Time Continuous Glucose Monitoring System Compared with Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in France
    Stéphane Roze
    John J. Isitt
    Jayne Smith-Palmer
    Peter Lynch
    Brigitte Klinkenbijl
    Gerald Zammit
    Pierre-Yves Benhamou
    Diabetes Therapy, 2021, 12 : 235 - 246
  • [42] Study protocol for optimising glycaemic control in type 1 diabetes treated with multiple daily insulin injections: intermittently scanned continuous glucose monitoring, carbohydrate counting with automated bolus calculation, or both? A randomised controlled trial
    Secher, Anna Lilja
    Pedersen-Bjergaard, Ulrik
    Svendsen, Ole Lander
    Gade-Rasmussen, Birthe
    Almdal, Thomas P.
    Dorflinger, Liv
    Vistisen, Dorte
    Norgaard, Kirsten
    BMJ OPEN, 2020, 10 (04):
  • [43] Long-term cost-effectiveness of Dexcom G6 real-time continuous glucose monitoring system in people with type 1 diabetes in Australia
    Isitt, J. J.
    Roze, S.
    Tilden, D.
    Arora, N.
    Palmer, A. J.
    Jones, T.
    Rentoul, D.
    Lynch, P.
    DIABETIC MEDICINE, 2022, 39 (07)
  • [44] Assessing the efficiency of using Continuous Subcutaneous Insulin-Infusion (CSII) versus Multiple Daily Injections (MDI) in Spanish Diabetes Mellitus type-1 (DM1) patients. Cost-effectiveness analysis
    Castell, C
    Palmer, AJ
    Rodriguez, JM
    Roze, S
    Serrano-Contreras, D
    Zakrzewska, K
    VALUE IN HEALTH, 2005, 8 (06) : A161 - A161
  • [45] Insulin Patch Pump Therapy vs. Multiple Daily Injections (MDI) in 2,729 Youth with Type 1 Diabetes (T1D): Data from the German-Austrian DPV-Registry
    Danne, Thomas
    Heidtmann, Bettina
    Rami-Merhar, Birgit
    Ziegler, Ralph
    Holl, Reinhard W.
    DIABETES, 2016, 65 : A340 - A340
  • [46] Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada
    Roze, Stephane
    Isitt, John J.
    Smith-Palmer, Jayne
    Lynch, Peter
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2021, 13 : 717 - 725
  • [47] Therapy adjustments in people with type 1 diabetes with impaired hypoglycemia awareness on multiple daily injections using real-time continuous glucose monitoring: a mechanistic analysis of the HypoDE study
    Waldenmaier, Delia
    Freckmann, Guido
    Pleus, Stefan
    Hermanns, Norbert
    Ehrmann, Dominic
    Heinemann, Lutz
    Haug, Cornelia
    BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)
  • [48] Improvement of Selected Psychological Parameters and Quality of Life of Patients With Type 1 Diabetes Mellitus Undergoing Transition From Multiple Daily Injections and Self-Monitoring of Blood Glucose Directly to the MiniMed 780G Advanced Hybrid Closed-Loop System: Post hoc Analysis of a Randomized Control Study
    Cyranka, Katarzyna
    Matejko, Bartlomiej
    Juza, Anna
    Kiec-Wilk, Beata
    Krzyzowska, Sabina
    Cohen, Ohad
    Da Silva, Julien
    Lushchyk, Maxim
    Malecki, Maciej T.
    Klupa, Tomasz
    JMIR FORMATIVE RESEARCH, 2023, 7
  • [49] Different Times for Different Metrics: Predicting 90 Days of Intermittently Scanned Continuous Glucose Monitoring Data in Subjects With Type 1 Diabetes on Multiple Daily Injection Therapy. Findings From a Multicentric Real-World Study
    Csermely, Alessandro
    Borella, Nicolo D.
    Turazzini, Anna
    Pilati, Martina
    Sheiban, Sara S.
    Bonadonna, Riccardo C.
    Trevisan, Roberto
    Trombetta, Maddalena
    Lepore, Giuseppe
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2025,
  • [50] Long-term cost-effectiveness of Dexcom G6 real-time continuous glucose monitoring system in people with type 1 diabetes in Australia: Response to letter from Hellmund, Richard and Welsh, Zoe
    Isitt, John J.
    Roze, Stephane
    DIABETIC MEDICINE, 2023, 40 (02)